Company Alopexx, Inc.
Equities
ALPX
US02052J1016
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gerald B. Pier
FOU | Founder | 72 | 23/19/23 |
Daniel R. Vlock
CEO | Chief Executive Officer | 72 | 23/19/23 |
Thomas T. Thomas
DFI | Director of Finance/CFO | 66 | 01/21/01 |
Corporate Officer/Principal | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Werth
BRD | Director/Board Member | 85 | - |
Ann MacDougall
BRD | Director/Board Member | 70 | - |
Richard Cohen
BRD | Director/Board Member | 73 | - |
William Chin
BRD | Director/Board Member | 76 | - |
Daniel R. Vlock
CEO | Chief Executive Officer | 72 | 23/19/23 |
Gail H. Cassell
BRD | Director/Board Member | 77 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,847,178 | 0 | 0 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+33.63% | 5.09TCr | |
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr |